Cargando…
Current Status of the Use of Multifunctional Enzymes as Anti-Cancer Drug Targets
Fighting cancer is one of the major challenges of the 21st century. Among recently proposed treatments, molecular-targeted therapies are attracting particular attention. The potential targets of such therapies include a group of enzymes that possess the capability to catalyze at least two different...
Autores principales: | Teixeira, Carla S. S., Sousa, Sérgio F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780674/ https://www.ncbi.nlm.nih.gov/pubmed/35056904 http://dx.doi.org/10.3390/pharmaceutics14010010 |
Ejemplares similares
-
Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses
por: Siafaka, Panoraia I., et al.
Publicado: (2016) -
Multifunctional Proteins: Involvement in Human Diseases and Targets of Current Drugs
por: Franco-Serrano, Luis, et al.
Publicado: (2018) -
The current status of anti-GPCR drugs against different cancers
por: Usman, Sana, et al.
Publicado: (2020) -
Alone and together: current approaches to targeting glutaminase enzymes as part of anti-cancer therapies
por: Nguyen, Thuy-Tien T, et al.
Publicado: (2023) -
Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology
por: Crisci, Stefania, et al.
Publicado: (2019)